Does TRIAMCINOLONE Cause Choroidal neovascularisation? 5 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Choroidal neovascularisation have been filed in association with TRIAMCINOLONE. This represents 0.1% of all adverse event reports for TRIAMCINOLONE.
5
Reports of Choroidal neovascularisation with TRIAMCINOLONE
0.1%
of all TRIAMCINOLONE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Choroidal neovascularisation From TRIAMCINOLONE?
Of the 5 reports.
Is Choroidal neovascularisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIAMCINOLONE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TRIAMCINOLONE Cause?
Drug ineffective (3,035)
Psoriasis (1,131)
Off label use (901)
Product use in unapproved indication (724)
Condition aggravated (625)
Therapeutic product effect incomplete (624)
Treatment failure (612)
Drug intolerance (527)
Nausea (525)
Pruritus (485)
What Other Drugs Cause Choroidal neovascularisation?
RANIBIZUMAB (195)
PEGCETACOPLAN (52)
AFLIBERCEPT (47)
VERTEPORFIN (47)
BEVACIZUMAB (38)
BROLUCIZUMAB-DBLL (38)
PENTOSAN POLYSULFATE (17)
PREDNISONE (10)
SILDENAFIL (10)
LUCENTIS (9)
Which TRIAMCINOLONE Alternatives Have Lower Choroidal neovascularisation Risk?
TRIAMCINOLONE vs TRIAMCINOLONE ACETONIDE
TRIAMCINOLONE vs TRIAMCINOLONE HEXACETONIDE
TRIAMCINOLONE vs TRIAMTERENE
TRIAMCINOLONE vs TRIATEC
TRIAMCINOLONE vs TRIAZOLAM